Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

doi:10.1007/s00415-017-8462-7

Case Reports

. 2017 May;264(5):1011-1014.

doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23.

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

Daniele Velardo¹, Nilo Riva², Ubaldo Del Carro³, Francesca Bianchi³, Giancarlo Comi², Raffaella Fazio²

Affiliations

¹ Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy. velardo.daniele@gmail.com.
² Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
³ Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.

PMID: 28337614
DOI: 10.1007/s00415-017-8462-7

Case Reports

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

Daniele Velardo et al. J Neurol. 2017 May.

. 2017 May;264(5):1011-1014.

doi: 10.1007/s00415-017-8462-7. Epub 2017 Mar 23.

Authors

Daniele Velardo¹, Nilo Riva², Ubaldo Del Carro³, Francesca Bianchi³, Giancarlo Comi², Raffaella Fazio²

Affiliations

¹ Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy. velardo.daniele@gmail.com.
² Division of Neuroscience, Department of Neurology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.
³ Division of Neuroscience, Department of Neurophysiology, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Via Olgettina 48, Milan, 20132, Italy.

PMID: 28337614
DOI: 10.1007/s00415-017-8462-7

No abstract available

PubMed Disclaimer

Cited by

Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
Shimizu S, Iijima M, Fukami Y, Tamura N, Nakatochi M, Ando M, Nishi R, Koike H, Kaida K, Koga M, Kanda T, Ogata H, Kira JI, Mori M, Kuwabara S, Katsuno M. Shimizu S, et al. JMIR Res Protoc. 2020 Apr 1;9(4):e17117. doi: 10.2196/17117. JMIR Res Protoc. 2020. PMID: 32234705 Free PMC article.
Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.
Fisse AL, Motte J, Grüter T, Sgodzai M, Pitarokoili K, Gold R. Fisse AL, et al. Neurol Res Pract. 2020 Dec 8;2:42. doi: 10.1186/s42466-020-00088-8. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324942 Free PMC article. Review.
Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study.
Zheng Y, Hu J, Sun C, Qiao K, Zhao Y, Liu B, Sun J, Xi J, Luo S, Lu J, Zhao C, Lin J. Zheng Y, et al. Front Neurol. 2024 Jan 31;15:1326874. doi: 10.3389/fneur.2024.1326874. eCollection 2024. Front Neurol. 2024. PMID: 38356878 Free PMC article.
Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.
Hu J, Sun C, Lu J, Zhao C, Lin J. Hu J, et al. J Neurol. 2022 Mar;269(3):1250-1263. doi: 10.1007/s00415-021-10646-y. Epub 2021 Jun 12. J Neurol. 2022. PMID: 34120208
Complement in neurological disorders and emerging complement-targeted therapeutics.
Dalakas MC, Alexopoulos H, Spaeth PJ. Dalakas MC, et al. Nat Rev Neurol. 2020 Nov;16(11):601-617. doi: 10.1038/s41582-020-0400-0. Epub 2020 Oct 1. Nat Rev Neurol. 2020. PMID: 33005040 Free PMC article. Review.

See all "Cited by" articles

References

1. Eur J Neurol. 2004 Nov;11(11):788 - PubMed
1. J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85 - PubMed
1. J Child Neurol. 2014 Jan;29(1):43-8 - PubMed
1. Rheumatol Int. 2012 Dec;32(12):4061-3 - PubMed
1. J Neurol Neurosurg Psychiatry. 1999 May;66(5):677-80 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

[1] Eur J Neurol. 2004 Nov;11(11):788 - PubMed

[2] Eur J Neurol. 2004 Nov;11(11):788 - PubMed

[3] J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85 - PubMed

[4] J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):973-85 - PubMed

[5] J Child Neurol. 2014 Jan;29(1):43-8 - PubMed

[6] J Child Neurol. 2014 Jan;29(1):43-8 - PubMed

[7] Rheumatol Int. 2012 Dec;32(12):4061-3 - PubMed

[8] Rheumatol Int. 2012 Dec;32(12):4061-3 - PubMed

[9] J Neurol Neurosurg Psychiatry. 1999 May;66(5):677-80 - PubMed

[10] J Neurol Neurosurg Psychiatry. 1999 May;66(5):677-80 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

Affiliations

Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources